Net Income (Loss) Attributable to Parent in USD of Biofrontera Inc. from Q3 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Biofrontera Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q3 2020 to Q3 2025.
  • Biofrontera Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$6.65M, a 17.3% decline year-over-year.
  • Biofrontera Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$17.6M, a 36.9% decline year-over-year.
  • Biofrontera Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$17.8M, a 11.8% increase from 2023.
  • Biofrontera Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$20.1M, a 3045% decline from 2022.
  • Biofrontera Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$640K, a 98.3% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Biofrontera Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$17.6M -$6.65M -$980K -17.3% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 -$16.6M -$5.32M -$5.07M -1972% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 -$11.5M -$4.2M +$6.23M +59.7% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 -$17.8M -$1.4M -$4.92M -140% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 -$12.8M -$5.67M +$673K +10.6% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 -$13.5M -$257K +$9.58M +97.4% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 -$23.1M -$10.4M -$2.96M -39.6% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 -$20.1M $3.53M +$6.31M 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 -$26.4M -$6.34M -$3.78M -147% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$22.7M -$9.84M -$8.99M -1057% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$13.7M -$7.48M -$13M -234% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 -$640K -$2.79M +$11.7M +80.8% 01 Oct 2022 31 Dec 2022 10-K 15 Mar 2024
Q3 2022 -$12.4M -$2.57M +$13.4M +84% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$25.8M -$850K +$2.81M +76.8% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023
Q1 2022 -$28.6M $5.56M +$9.1M 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 -$37.7M -$14.5M 01 Oct 2021 31 Dec 2021 8-K 03 Oct 2023
Q3 2021 -$16M -$13M -436% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$3.66M 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 -$3.53M 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022
Q3 2020 -$2.99M 01 Jul 2020 30 Sep 2020 10-Q 30 Nov 2021

Biofrontera Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$17.8M +$2.37M +11.8% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 -$20.1M -$19.5M -3045% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
2022 -$640K +$37.1M +98.3% 01 Jan 2022 31 Dec 2022 10-K 15 Mar 2024
2021 -$37.7M -$26.7M -243% 01 Jan 2021 31 Dec 2021 8-K 03 Oct 2023
2020 -$11M 01 Jan 2020 31 Dec 2020 10-K 11 Apr 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.